AU3632595A - Porcine antibodies to tnf-alpha(alpha) - Google Patents

Porcine antibodies to tnf-alpha(alpha)

Info

Publication number
AU3632595A
AU3632595A AU36325/95A AU3632595A AU3632595A AU 3632595 A AU3632595 A AU 3632595A AU 36325/95 A AU36325/95 A AU 36325/95A AU 3632595 A AU3632595 A AU 3632595A AU 3632595 A AU3632595 A AU 3632595A
Authority
AU
Australia
Prior art keywords
alpha
tnf
porcine antibodies
porcine
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU36325/95A
Inventor
Chung-Ho Hung
Kurt B. Osther
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Verigen Inc
Original Assignee
Verigen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Verigen Inc filed Critical Verigen Inc
Publication of AU3632595A publication Critical patent/AU3632595A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241Tumor Necrosis Factors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU36325/95A 1994-09-15 1995-09-15 Porcine antibodies to tnf-alpha(alpha) Withdrawn AU3632595A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US30638194A 1994-09-15 1994-09-15
US306381 1994-09-15
US45301395A 1995-05-30 1995-05-30
US453013 1995-05-30
PCT/US1995/011700 WO1996008516A1 (en) 1994-09-15 1995-09-15 PORCINE ANTIBODIES TO TNF-α(ALPHA)

Publications (1)

Publication Number Publication Date
AU3632595A true AU3632595A (en) 1996-03-29

Family

ID=26975130

Family Applications (1)

Application Number Title Priority Date Filing Date
AU36325/95A Withdrawn AU3632595A (en) 1994-09-15 1995-09-15 Porcine antibodies to tnf-alpha(alpha)

Country Status (2)

Country Link
AU (1) AU3632595A (en)
WO (1) WO1996008516A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2859725B1 (en) * 2003-09-16 2006-03-10 Neovacs HIGH EFFICIENCY PROCESS FOR OBTAINING HUMAN ANTIBODIES THAT NEUTRALIZE THE BIOLOGICAL ACTIVITY OF A HUMAN CYTOKINE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2638652B2 (en) * 1988-07-18 1997-08-06 カイロン・コーポレーション Monoclonal antibody reacting with cachectin
WO1990001066A1 (en) * 1988-07-26 1990-02-08 Bio-Research Laboratories, Inc. Porcine polyclonal and monoclonal antibodies

Also Published As

Publication number Publication date
WO1996008516A1 (en) 1996-03-21

Similar Documents

Publication Publication Date Title
AU5632794A (en) Absorbent composite
AU3811495A (en) Antibodies
AU5267190A (en) Modified antibodies
AU2749895A (en) Structural cellular component
AU7624294A (en) Framed structure
AU2696795A (en) Shrinkage reduction cement composition
AU7266591A (en) Method and composition for enhancing performance
AU1360395A (en) Low buffer nutritional composition
AU9011098A (en) Convertible table system
AU1608595A (en) Adhesive composition
AU7796291A (en) High affinity antibodies to small peptides
AU3632595A (en) Porcine antibodies to tnf-alpha(alpha)
AU6059194A (en) Monoclonal antibodies to bovine cytokines
AU2992997A (en) Recombinant crab collagenase
AU5966596A (en) Antibodies to porcine cd34 positive cells and uses therefor
AU3622495A (en) Improvements to engines
AU7862291A (en) Modified antibodies
AU1617495A (en) Novel protein PHBP-70
AU1049895A (en) Methods relating to ir-95
AU7859291A (en) Switched lampholder
AU1365195A (en) Structural truss
AU7754094A (en) Improvements to framing members
AU3994595A (en) Memo for forearm
AU2003204091A1 (en) Porcine cell interaction proteins
AU7799998A (en) Method to reverse mydriasis